Competing Endogenous RNA of Snail and Zeb1 UTR in Therapeutic Resistance of Colorectal Cancer

Nam Hee Kim1, Sang Hyun Song1, Yun Hee Choi1

  • 1Department of Oral Pathology, Yonsei University College of Dentistry, Seoul 03722, Korea.

Insights

The epithelial-mesenchymal transition (EMT) involves competing endogenous RNA (ceRNA) networks in colorectal cancer. These networks, involving EMT-inducers and tumor suppressive microRNAs, impact cancer progression and therapeutic resistance.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • The epithelial-mesenchymal transition (EMT) is crucial for cancer progression and therapeutic resistance.
  • Protein abundance of EMT-inducers like Snail and Zeb1 is well-studied, but interactions via untranslated regions (UTRs) in competing endogenous RNA (ceRNA) networks are less understood.

Purpose of the Study:

  • To investigate the role of ceRNA networks in regulating EMT-inducers Snail and Zeb1 in colorectal cancer (CRC).
  • To explore the functional impact of these ceRNA networks on EMT phenotype and therapeutic resistance in colon cancer.

Main Methods:

  • Analysis of synchronized transcript abundance of Snail and Zeb1.
  • Identification of a trans-regulatory ceRNA network involving UTRs of EMT inducers and tumor suppressive miRNAs (miR-34, miR-200).
  • Examination of The Cancer Genome Atlas (TCGA) samples for genome-wide ceRNA gene sets regulated by miR-34a and miR-200.

Main Results:

  • A non-coding RNA network synchronizes Snail and Zeb1 transcript abundance in colorectal cancer.
  • A trans-regulatory ceRNA network mediated by miR-34 and miR-200 competition within EMT inducer UTRs was identified.
  • This ceRNA network was found to be functional in the EMT phenotype and therapeutic resistance of colon cancer.
  • Genome-wide ceRNA gene sets regulated by miR-34a and miR-200 were observed in TCGA colorectal cancer samples.

Conclusions:

  • ceRNA networks involving reciprocal interactions between EMT gene UTRs and tumor suppressive microRNAs are functional in colorectal cancer progression.
  • These networks play a significant role in the therapeutic resistance of colorectal cancer cells.
  • Understanding these ceRNA networks offers potential therapeutic targets for colorectal cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.3K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.8K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.2K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
57.8K